Understanding Accretion/Dilution Analysis: Step-by-Step Guide

Accretion/dilution analysis sits at the heart of every M&A transaction evaluation in investment banking. When a company announces an acquisition, the first question management, boards, and investors ask is simple but critical: will this deal increase or decrease our earnings per share?

This analysis determines whether an acquisition is accretive (increases the acquirer's EPS) or dilutive (decreases EPS), providing a clear, quantifiable measure of the deal's immediate financial impact on shareholders. While not the only consideration in M&A decisions, accretion/dilution analysis serves as a crucial screening mechanism that can make or break deal approval, especially for strategic acquirers answerable to public shareholders.

In investment banking interviews, you'll face questions about calculating accretion/dilution, understanding the drivers that make deals accretive or dilutive, and explaining how different deal structures impact EPS. This guide provides a comprehensive, step-by-step framework for mastering accretion/dilution analysis, complete with formulas, worked examples, and the key insights interviewers expect you to understand.

What is Accretion/Dilution Analysis?

The Core Concept

Accretion/dilution analysis measures the impact of an acquisition on the acquirer's earnings per share by comparing standalone EPS before the deal to pro forma EPS after combining the two companies. The analysis answers a fundamental question: are shareholders better or worse off from an earnings perspective after this transaction?

The calculation compares two scenarios:

Standalone EPS (Pre-Deal):

Pro Forma EPS (Post-Deal):

If pro forma EPS exceeds standalone EPS, the deal is accretive and creates immediate value for shareholders. If pro forma EPS falls below standalone EPS, the deal is dilutive and destroys value in the near term.

Why Accretion/Dilution Matters

For public company management, EPS is a closely watched metric that drives stock prices and compensation. Announcing a dilutive acquisition often triggers negative market reactions, as investors perceive immediate earnings destruction. Management teams are therefore extremely sensitive to accretion/dilution and often structure deals specifically to achieve accretion.

For investment bankers, accretion/dilution analysis serves multiple purposes. It helps clients evaluate deal attractiveness, supports negotiations around purchase price and deal structure, and provides ammunition for board presentations and investor communications. Understanding the drivers of accretion/dilution also helps bankers propose creative deal structures that minimize dilution.

For private equity firms, while accretion/dilution matters less than it does for public strategic buyers (since PE firms focus on IRR and cash returns), the analysis still applies when PE-backed companies make add-on acquisitions or when evaluating take-private transactions.

Accretive vs. Dilutive: The Math

The percentage accretion or dilution is calculated as:

For example, if standalone EPS is $2.00 and pro forma EPS is $2.10, the deal is 5% accretive. If pro forma EPS falls to $1.90, the deal is 5% dilutive.

Investment bankers typically model accretion/dilution across multiple years (usually 3-5 years post-close) because many deals that are initially dilutive become accretive as synergies are realized and revenue growth accelerates.

The Step-by-Step Calculation Process

Step 1: Determine the Purchase Price

The first step is calculating the total purchase price the acquirer will pay for the target company. This includes both the equity value paid to target shareholders and the assumption of any net debt.

Calculate Equity Purchase Price:

Most acquirers pay a premium above the target's current trading price to incentivize shareholders to sell. Typical premiums range from 20-40% for public company acquisitions, though this varies significantly by industry, strategic rationale, and competitive bidding dynamics.

Add Net Debt Assumed:

The enterprise value represents the total investment the acquirer is making. While only equity purchase price affects the accretion/dilution calculation directly, understanding enterprise value is critical for evaluating deal economics holistically.

Step 2: Determine the Deal Structure

Deal structure dramatically impacts accretion/dilution because it determines how many new shares are issued and how much debt is added. The three primary consideration types are cash, stock, and assumed debt.

All-Cash Deal:

All-Stock Deal:

- More dilutive due to increased share count

Mixed Consideration:

Step 3: Calculate Pro Forma Net Income

Pro forma net income combines the earnings power of both companies while adjusting for transaction impacts including interest expense, synergies, and one-time costs.

Basic Pro Forma Net Income Formula:

Let's break down each component:

Acquirer Net Income: The buyer's standalone net income, typically from the most recent fiscal year or forward projections.

Target Net Income: The target's standalone net income, adjusted for any one-time items or pro forma adjustments.

Cost Synergies (After-Tax): Expected cost savings from eliminating duplicate functions, consolidating facilities, or achieving economies of scale. Apply the tax rate:

New Interest Expense (After-Tax): If debt is used to finance the acquisition, calculate the additional interest expense:

The after-tax calculation reflects the tax deductibility of interest, which reduces the true cost of debt financing.

Step 4: Calculate Pro Forma Shares Outstanding

Pro forma share count equals the acquirer's current shares plus any new shares issued to finance the acquisition or pay target shareholders.

Use fully diluted shares for the acquirer, which includes the impact of stock options, restricted stock units, and convertible securities. This provides a more conservative and realistic view of ownership dilution.

For stock consideration, calculate new shares issued as:

If the deal is 50% cash ($500M) and 50% stock ($500M), and the acquirer trades at $50 per share, the acquirer issues 10 million new shares ($500M / $50).

Step 5: Calculate Pro Forma EPS

With pro forma net income and share count determined, calculating pro forma EPS is straightforward:

Compare this to the acquirer's standalone EPS to determine accretion or dilution.

Step 6: Calculate the Accretion/Dilution Percentage

The final step quantifies the magnitude of accretion or dilution:

Express the result as a percentage. Deals with single-digit accretion (1-5%) are considered modestly accretive, while 10%+ accretion is viewed as highly attractive. Even modest dilution (2-3%) often raises concerns with public company boards.

Master interview fundamentals: Practice 400+ technical and behavioral questions including accretion/dilution calculations, download our iOS app for comprehensive M&A modeling prep.

Worked Example: Complete Accretion/Dilution Analysis

The Transaction Overview

Let's work through a complete example with realistic numbers:

Step-by-Step Calculation

1. Calculate Purchase Price:

Equity purchase price: $50 × 50M shares = $2.5B

Cash consideration: $2.5B × 60% = $1.5B

Stock consideration: $2.5B × 40% = $1.0B

2. Calculate New Shares Issued:

New shares = $1.0B / $80 = 12.5M shares

Pro forma shares = 100M + 12.5M = 112.5M shares

3. Calculate After-Tax Interest Expense:

New interest = $1.2B × 5% = $60M

After-tax interest = $60M × (1 - 25%) = $45M

4. Calculate After-Tax Synergies:

After-tax synergies = $50M × (1 - 25%) = $37.5M

5. Calculate Pro Forma Net Income:

Pro forma NI = $500M (TechCo) + $100M (StartupCo) + $37.5M (synergies) - $45M (interest) = $592.5M

6. Calculate Pro Forma EPS:

Pro forma EPS = $592.5M / 112.5M shares = $5.27

7. Calculate Accretion/Dilution:

Accretion = ($5.27 - $5.00) / $5.00 = 5.4% accretive

This deal is accretive despite the share dilution and additional interest expense because the target's earnings contribution and cost synergies more than offset these dilutive factors.

Key Drivers of Accretion and Dilution

The P/E Multiple Rule

For all-stock deals with no synergies, there's a simple rule: the deal is accretive if the target's P/E ratio is lower than the acquirer's P/E ratio, and dilutive if the target's P/E is higher.

Why this works: When an acquirer with a high P/E (expensive stock) buys a target with a low P/E (cheaper stock), it's effectively buying earnings at a discount. Each dollar of target earnings costs fewer shares than those earnings would be worth at the acquirer's higher valuation.

Example: If the acquirer has a 20x P/E and the target has a 15x P/E, the all-stock deal is accretive. If the target has a 25x P/E, the deal is dilutive.

This rule breaks down when synergies, transaction costs, or debt financing are involved, but it provides a quick initial assessment for stock deals.

Deal Structure Impact

Cash-financed deals are generally more accretive than stock-financed deals because they avoid share dilution. However, cash deals require financing, which introduces other considerations:

Mixed consideration allows acquirers to optimize the trade-off between accretion and balance sheet impact.

Synergies: The Accretion Multiplier

Cost synergies are the most powerful driver of accretion because they directly increase pro forma earnings without any corresponding dilutive impact. Common synergy sources include:

Revenue synergies (cross-selling, expanded distribution) can also drive accretion but are harder to quantify and more speculative, so bankers apply significant haircuts.

Typical synergy assumptions range from 5-15% of the target's cost base, with higher percentages justified for highly overlapping businesses and lower percentages for diversifying acquisitions.

Interest Expense: The Hidden Diluter

Many candidates forget that debt-financed acquisitions reduce EPS through additional interest expense, even when no shares are issued. The after-tax cost of debt matters:

At a 5% interest rate and 25% tax rate, the after-tax cost is 3.75%. For every $1B in debt financing, this reduces pro forma net income by $37.5M annually.

Low interest rate environments make debt-financed acquisitions more attractive from an accretion perspective, while rising rates increase the dilutive impact of leverage.

Get the complete guide: Download our comprehensive 160-page PDF covering all M&A technical concepts and frameworks, access the IB Interview Guide for detailed merger modeling examples.

Beyond Year 1: Multi-Year Accretion Analysis

Why Year 1 Doesn't Tell the Full Story

Many acquisitions that are initially dilutive become accretive in years 2-3 as synergies ramp up and revenue growth accelerates. This is especially common for high-growth acquisitions where the target's earnings trajectory outpaces the acquirer's.

Investment bankers typically model accretion/dilution across a 3-5 year forecast period to show the full picture:

Year 1: May be 2% dilutive due to integration costs and slow synergy realization

Year 2: Becomes neutral as synergies reach 50% of target

Year 3+: Achieves 5-10% accretion with full synergies and revenue growth

This trajectory helps management defend deals that are initially dilutive but create long-term value.

Integration Costs and Restructuring Charges

One-time costs associated with integrations (severance, facility closures, system conversions) can further depress Year 1 earnings. While these are often excluded from pro forma calculations as "non-recurring," they do impact reported GAAP earnings and should be considered.

Revenue Growth Differentials

If the target is growing faster than the acquirer, even a dilutive Year 1 can quickly flip to accretion. A target growing at 20% annually versus an acquirer growing at 5% will contribute an increasingly large share of combined earnings.

Conversely, if growth slows post-acquisition (common when entrepreneurial targets are integrated into large bureaucratic acquirers), the accretion picture can deteriorate over time.

Common Interview Questions on Accretion/Dilution

Question 1: "Walk me through an accretion/dilution analysis"

How to answer: Use the six-step framework outlined above, being specific about each calculation:

"First, I'd calculate the purchase price by multiplying the offer price per share by target shares outstanding. Second, I'd determine the deal structure—what percentage is cash versus stock—to calculate new shares issued. Third, I'd build pro forma net income by adding acquirer and target earnings, adding after-tax synergies, and subtracting after-tax interest expense from any debt financing. Fourth, I'd calculate pro forma shares by adding the acquirer's diluted shares to new shares issued. Fifth, I'd divide pro forma net income by pro forma shares to get pro forma EPS. Finally, I'd compare pro forma EPS to the acquirer's standalone EPS to determine accretion or dilution."

For more guidance on walking through M&A analyses, see our post on how to answer walk me through a deal.

Question 2: "What makes an acquisition accretive or dilutive?"

How to answer: "The key drivers are the relative P/E multiples, deal structure, synergies, and financing costs. In an all-stock deal with no synergies, the deal is accretive if the target's P/E is lower than the acquirer's. Cash consideration is generally more accretive than stock because it avoids dilution, though debt financing adds interest expense that's dilutive. Synergies are the most powerful driver of accretion because they increase earnings without corresponding dilution. Integration costs, transaction fees, and slow synergy realization can make deals dilutive in the near term even if they're attractive long-term."

Question 3: "If a deal is dilutive, does that mean it's a bad deal?"

How to answer: "Not necessarily. Dilution measures only the immediate EPS impact, but doesn't capture strategic value, long-term growth potential, or synergies that take time to realize. A deal might be dilutive in Year 1 but highly accretive by Year 3 once synergies are fully captured and revenue growth accelerates. Additionally, strategic considerations like acquiring critical technology, entering new markets, or eliminating competitors may justify short-term dilution. That said, public company management teams are very sensitive to dilution because investors focus heavily on EPS, so they'll typically structure deals to minimize dilution even if it means taking on more debt or reducing the premium paid."

To understand how dilution fits into broader M&A analysis, review our guide on types of mergers and acquisitions.

Question 4: "How would you make a dilutive deal accretive?"

How to answer: "There are several levers. First, increase the cash portion of consideration to reduce share dilution, potentially by raising debt. Second, identify and capture more synergies—even modest additional cost savings can flip dilution to accretion. Third, negotiate a lower purchase price or premium to reduce the earnings you need to generate. Fourth, structure the deal as an earnout where some consideration is contingent on performance targets, reducing upfront dilution. Fifth, accelerate synergy realization by planning integration more aggressively. Finally, you could adjust the financing mix, like using cheaper debt if available, though this increases financial risk."

Limitations of Accretion/Dilution Analysis

What Accretion/Dilution Misses

While accretion/dilution analysis is a standard M&A tool, it has significant limitations that candidates should understand:

Ignores cash flow: EPS is an accounting metric that doesn't reflect cash generation, which is what ultimately matters for returns and valuation.

Short-term focus: Emphasizing Year 1 accretion can cause management to reject deals that create long-term value but are initially dilutive.

No risk adjustment: Accretive deals aren't necessarily good deals if they increase risk, destroy strategic positioning, or misallocate capital.

Doesn't value growth: A deal can be accretive but still destroy value if the acquirer overpays relative to the growth and returns the target can generate.

Complementary Analyses

Investment bankers never rely solely on accretion/dilution. Comprehensive M&A analysis includes:

For more on valuation approaches in M&A, see our guide on enterprise value vs equity value.

Practical Tips for Interview Success

Build the Analysis Methodically

When given an accretion/dilution case study in interviews, resist the urge to jump straight to calculations. Instead:

1. Clarify assumptions: Ask about tax rates, financing structure, synergies, and time horizon 2. Outline your approach: Walk through the six steps before calculating anything 3. Show your work: Write out formulas and intermediate calculations so interviewers can follow your logic 4. Sanity check results: If you calculate 50% accretion, something is probably wrong

Know the Shortcuts

For all-stock deals with no synergies, use the P/E multiple rule to quickly assess whether the deal is likely accretive or dilutive before doing full calculations.

For deals with debt financing, remember that each $1B of debt at 5% interest reduces after-tax earnings by roughly $37.5M (assuming 25% tax rate).

Connect to Broader M&A Concepts

Strong candidates connect accretion/dilution to other M&A topics. For example:

"While this deal is 2% dilutive in Year 1, the strategic rationale is compelling because it gives the acquirer access to the target's distribution network, which should drive revenue synergies not captured in this initial analysis. Additionally, the target's faster growth rate means this should flip to accretive by Year 2."

This demonstrates that you understand accretion/dilution as one input to M&A decisions, not the only factor.

Key Takeaways

Accretion/dilution analysis is a fundamental M&A tool that measures the immediate EPS impact of acquisitions on the acquiring company's shareholders. Mastering this analysis requires understanding both the mechanical calculations and the strategic drivers.

Essential principles to remember:

For interview preparation:

Remember the key formulas:

Pro Forma EPS drives the entire analysis, calculated as combined net income divided by pro forma shares outstanding, with adjustments for synergies and financing costs.

Accretion/dilution percentage quantifies the impact, showing how much shareholder value is created or destroyed on an EPS basis.

Conclusion

Accretion/dilution analysis is non-negotiable knowledge for investment banking interviews and M&A advisory work. While experienced bankers can run these calculations in their sleep, the analysis requires careful attention to detail, clear understanding of drivers, and the judgment to interpret results in the context of broader deal strategy.

As you prepare for interviews, practice building accretion/dilution models from scratch with different deal structures, financing assumptions, and synergy scenarios. The more repetitions you do, the more intuitive the analysis becomes, and the better you'll be able to handle curve balls interviewers throw at you (like asking what happens if the deal is 70% stock instead of 50%, or if synergies are $75M instead of $50M).

Most importantly, remember that accretion/dilution is a screening tool and communication device, not a comprehensive measure of deal value. The best candidates demonstrate technical mastery of the calculations while also understanding the strategic context, limitations, and complementary analyses that inform real-world M&A decisions. This balanced perspective is what separates candidates who can pass interviews from those who can excel as investment banking analysts.

Start practicing accretion/dilution calculations with the framework and examples in this guide. Work through different scenarios, test your understanding of the drivers, and prepare to walk interviewers through your analysis with confidence and clarity.